Details for New Drug Application (NDA): 062758
✉ Email this page to a colleague
The generic ingredient in ERYZOLE is erythromycin ethylsuccinate; sulfisoxazole acetyl. There are one hundred and three drug master file entries for this compound. Additional details are available on the erythromycin ethylsuccinate; sulfisoxazole acetyl profile page.
Summary for 062758
Tradename: | ERYZOLE |
Applicant: | Alra |
Ingredient: | erythromycin ethylsuccinate; sulfisoxazole acetyl |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | GRANULE;ORAL | Strength | EQ 200MG BASE/5ML;EQ 600MG BASE/5ML | ||||
Approval Date: | Jun 15, 1988 | TE: | RLD: | No |
Complete Access Available with Subscription